Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.4%
    Check dated 2025-09-06T21:23:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and references to states and cities.
    Difference
    96%
    Check dated 2025-08-30T15:44:06.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:30:35.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T08:02:50.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T04:04:58.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, indicating a potential improvement or update in the content or functionality.
    Difference
    0.8%
    Check dated 2025-07-26T00:51:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.